ES8404858A1 - Un procedimiento para la purificacion de un anticuerpo. - Google Patents

Un procedimiento para la purificacion de un anticuerpo.

Info

Publication number
ES8404858A1
ES8404858A1 ES521371A ES521371A ES8404858A1 ES 8404858 A1 ES8404858 A1 ES 8404858A1 ES 521371 A ES521371 A ES 521371A ES 521371 A ES521371 A ES 521371A ES 8404858 A1 ES8404858 A1 ES 8404858A1
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
affinity purification
antibodies
antigens
environment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES521371A
Other languages
English (en)
Spanish (es)
Other versions
ES521371A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of ES521371A0 publication Critical patent/ES521371A0/es
Publication of ES8404858A1 publication Critical patent/ES8404858A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES521371A 1982-04-12 1983-04-11 Un procedimiento para la purificacion de un anticuerpo. Expired ES8404858A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36778182A 1982-04-12 1982-04-12

Publications (2)

Publication Number Publication Date
ES521371A0 ES521371A0 (es) 1984-05-16
ES8404858A1 true ES8404858A1 (es) 1984-05-16

Family

ID=23448565

Family Applications (3)

Application Number Title Priority Date Filing Date
ES521371A Expired ES8404858A1 (es) 1982-04-12 1983-04-11 Un procedimiento para la purificacion de un anticuerpo.
ES528001A Expired ES8706964A1 (es) 1982-04-12 1983-12-13 Un procedimiento para fraccionar anticuerpos de suero.
ES528000A Granted ES528000A0 (es) 1982-04-12 1983-12-13 Un procedimiento para la purificacion de un antigeno.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES528001A Expired ES8706964A1 (es) 1982-04-12 1983-12-13 Un procedimiento para fraccionar anticuerpos de suero.
ES528000A Granted ES528000A0 (es) 1982-04-12 1983-12-13 Un procedimiento para la purificacion de un antigeno.

Country Status (11)

Country Link
EP (1) EP0105359A4 (enExample)
AT (1) AT393386B (enExample)
AU (1) AU622099B2 (enExample)
CA (1) CA1209907A (enExample)
CH (1) CH672028A5 (enExample)
DK (1) DK192191A (enExample)
ES (3) ES8404858A1 (enExample)
FI (1) FI88403C (enExample)
GB (1) GB2128630B (enExample)
IT (1) IT1219779B (enExample)
WO (1) WO1983003678A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4859611A (en) * 1985-02-28 1989-08-22 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) * 1987-03-23 1992-12-29 Amgen Inc. Methods for purification of platelet-derived growth factor
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
SE468653B (sv) * 1987-03-06 1993-02-22 Perstorp Biolytica Adsorbent foer isokratisk affinitetskromatografi
JPS6463599A (en) * 1987-05-01 1989-03-09 Xoma Corp Purification of immunoglobulin by selective anti-idiotype bond
JPH03500682A (ja) * 1987-07-14 1991-02-14 ザ　ビクトリア　ユニヴアーシテイ　オブ　マンチエスター 診断方法
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US20030017147A1 (en) * 1996-09-20 2003-01-23 Guy L Reed Composition and method for enhancing fibrinolysis
TW201920257A (zh) * 2008-04-11 2019-06-01 日商中外製藥股份有限公司 重複結合複數個抗原的抗原結合分子
TWI654203B (zh) 2010-11-30 2019-03-21 Chugai Seiyaku Kabushiki Kaisha 具有鈣依存性的抗原結合能力之抗體
SG10201609665PA (en) 2011-02-25 2017-01-27 Chugai Pharmaceutical Co Ltd FcɣRIIb-SPECIFIC Fc ANTIBODY
JP6322411B2 (ja) 2011-09-30 2018-05-09 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
KR20210074395A (ko) 2011-11-30 2021-06-21 추가이 세이야쿠 가부시키가이샤 면역 복합체를 형성하는 세포내로의 운반체（캐리어）를 포함하는 의약
CA2865158C (en) 2012-02-24 2022-11-01 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule for promoting disappearance of antigen via fc.gamma.riib
EA201791366A1 (ru) 2014-12-19 2018-02-28 Чугаи Сейяку Кабусики Кайся Антитела к c5 и способы их применения
MX2017005774A (es) 2014-12-19 2017-07-28 Chugai Pharmaceutical Co Ltd Anticuerpos antimiostatina, polipeptidos que contienen regiones fc variantes, y metodos de uso.
CN114773469B (zh) 2015-02-05 2025-12-19 中外制药株式会社 包含离子浓度依赖性的抗原结合结构域的抗体，fc区变体，il-8-结合抗体及其应用
EP3394098A4 (en) 2015-12-25 2019-11-13 Chugai Seiyaku Kabushiki Kaisha ANTI-MYOSTATIN ANTIBODIES AND METHOD OF USE
CN116271014A (zh) 2016-08-05 2023-06-23 中外制药株式会社 用于预防或治疗il-8相关疾病的组合物
WO2018139623A1 (en) 2017-01-30 2018-08-02 Chugai Seiyaku Kabushiki Kaisha Anti-sclerostin antibodies and methods of use
CN110724204B (zh) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Fc融合蛋白的纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
DE3264713D1 (en) * 1981-02-26 1985-08-22 Unilever Plc A process and apparatus for the recovery of immunoglobulines
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
WO1983003678A1 (en) 1983-10-27
ES8506902A1 (es) 1985-08-01
AU622099B2 (en) 1992-04-02
DK192191D0 (da) 1991-11-26
ES521371A0 (es) 1984-05-16
FI834530A0 (fi) 1983-12-09
GB8332644D0 (en) 1984-01-11
EP0105359A4 (en) 1984-08-20
ATA901983A (de) 1991-03-15
CA1209907A (en) 1986-08-19
DK192191A (da) 1991-11-26
FI88403B (fi) 1993-01-29
AU7256987A (en) 1987-09-03
FI88403C (fi) 1993-05-10
AT393386B (de) 1991-10-10
GB2128630B (en) 1986-08-28
ES528001A0 (es) 1987-07-01
IT1219779B (it) 1990-05-24
ES8706964A1 (es) 1987-07-01
CH672028A5 (enExample) 1989-10-13
GB2128630A (en) 1984-05-02
ES528000A0 (es) 1985-08-01
FI834530L (fi) 1983-12-09
EP0105359A1 (en) 1984-04-18
IT8320550A0 (it) 1983-04-12

Similar Documents

Publication Publication Date Title
ES8706964A1 (es) Un procedimiento para fraccionar anticuerpos de suero.
AU549077B2 (en) Determination of antigens with monoclonal antibodies
AU564383B2 (en) Monoclonal antibody immunoassay
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
EP0098162A3 (en) Monoclonal antibodies specific to carcinoembryonic antigen
AU1518795A (en) Immunoassays for prostate specific antigen
DK0432249T3 (da) Monoklonale antistoffer over for beta-kæden i leukocytadhæsionsreceptoren, fremgangsmåder til fremstilling af disse antistoffer og anvendelse heraf
MY101457A (en) Toxins and antibodies of c.difficile.
AU564575B2 (en) Polyvalent endotoxin specific antibodies
AU567681B2 (en) Immunoassay involving monoclonal igm antibody
MY100328A (en) Toxins and antibodies of c.difficile
EP0287397A3 (en) Monoclonal antibody specific to human pancreatic phospholipase a2
CA2054689A1 (en) An immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen
ES8401261A1 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
GR852008B (enExample)
DK329789A (da) Monoklonalt antistof
AU546797B2 (en) Monoclonal antibodies against tumor antigens and method
EP0186371A3 (en) Monoclonal antibodies specific to antigens of hepatitis b virus
AU2900184A (en) Membrane antigens generated from pooled cells and monoclonal antibodies
EP0089771A3 (en) Atcc hb8116 and its monoclonal anti-h-y antibody, hyclonalan
DE3174878D1 (en) Immunoassay utilizing monoclonal high affinity igm antibodies
IT8821547A0 (it) Metodo immunologico per la determinazione di anticorpi anti antigeni di microorganismi, mediante anticorpi antiidiotipo e mezzi adatti allo scopo.
CA2178504A1 (en) Immunoassays for prostate specific antigen

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401